-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 B5ixJnhs4hTXy3xuhy4SM6EKJXvvFqTRpvycnQ3Jy1nXEnJOpOEe0VrVa5OMsCUN
 Enaf7krY0+s0WDfRVNLEgw==

<SEC-DOCUMENT>0001209191-05-002326.txt : 20050107
<SEC-HEADER>0001209191-05-002326.hdr.sgml : 20050107
<ACCEPTANCE-DATETIME>20050107163406
ACCESSION NUMBER:		0001209191-05-002326
CONFORMED SUBMISSION TYPE:	4/A
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20041230
FILED AS OF DATE:		20050107
DATE AS OF CHANGE:		20050107

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			GILMARTIN RAYMOND V
		CENTRAL INDEX KEY:			0001181176

	FILING VALUES:
		FORM TYPE:		4/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-03305
		FILM NUMBER:		05518614

	BUSINESS ADDRESS:	
		STREET 1:		MERCK & CO INC
		STREET 2:		ONE MERCK DR PO BOX 100
		CITY:			WHITEHOUSE STATION
		STATE:			NJ
		ZIP:			08889
		BUSINESS PHONE:		9084231000

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MERCK & CO INC
		CENTRAL INDEX KEY:			0000064978
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				221109110
		STATE OF INCORPORATION:			NJ
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		ONE MERCK DR
		STREET 2:		P O BOX 100
		CITY:			WHITEHOUSE STATION
		STATE:			NJ
		ZIP:			08889-0100
		BUSINESS PHONE:		9084234044

	MAIL ADDRESS:	
		STREET 1:		ONE MERCK DR
		STREET 2:		PO BOX 100 WS3AB-05
		CITY:			WHITEHOUSE STATION
		STATE:			NJ
		ZIP:			08889-0100
</SEC-HEADER>
<DOCUMENT>
<TYPE>4/A
<SEQUENCE>1
<FILENAME>doc4a.xml
<DESCRIPTION>FORM 4/A SUBMISSION
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0202</schemaVersion>

    <documentType>4/A</documentType>

    <periodOfReport>2004-12-30</periodOfReport>

    <dateOfOriginalSubmission>2004-12-30</dateOfOriginalSubmission>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0000064978</issuerCik>
        <issuerName>MERCK &amp; CO INC</issuerName>
        <issuerTradingSymbol>(MRK)</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001181176</rptOwnerCik>
            <rptOwnerName>GILMARTIN RAYMOND V</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>ONE MERCK DRIVE</rptOwnerStreet1>
            <rptOwnerStreet2>P.O. BOX 100</rptOwnerStreet2>
            <rptOwnerCity>WHITEHOUSE STATION</rptOwnerCity>
            <rptOwnerState>NJ</rptOwnerState>
            <rptOwnerZipCode>08889-0100</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>1</isDirector>
            <isOfficer>1</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle>COB, President, CEO</officerTitle>
        </reportingOwnerRelationship>
    </reportingOwner>

    <derivativeTable>
        <derivativeTransaction>
            <securityTitle>
                <value>Phantom Stock</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <footnoteId id="F1"/>
            </conversionOrExercisePrice>
            <transactionDate>
                <value>2004-12-30</value>
                <footnoteId id="F2"/>
            </transactionDate>
            <deemedExecutionDate></deemedExecutionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionTimeliness>
                <value></value>
            </transactionTimeliness>
            <transactionAmounts>
                <transactionShares>
                    <value>1629.4227</value>
                    <footnoteId id="F2"/>
                </transactionShares>
                <transactionPricePerShare>
                    <value>32.22</value>
                    <footnoteId id="F2"/>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <exerciseDate>
                <footnoteId id="F3"/>
            </exerciseDate>
            <expirationDate>
                <footnoteId id="F4"/>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>1629.4227</value>
                    <footnoteId id="F2"/>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>124813.6387</value>
                    <footnoteId id="F2"/>
                    <footnoteId id="F5"/>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeTransaction>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">1-for-1</footnote>
        <footnote id="F2">This Amended Form 4 is being filed to correct the transaction date as a result of a revised payroll date.  As a result of the revised execution date, the number of derivative securities acquired, number of underlying securities, price of derivative security and number of derivative securities beneficially owned following the reported transaction were adjusted.</footnote>
        <footnote id="F3">The Merck Deferral Program includes the right of redesignation to other investment measures within the Program.</footnote>
        <footnote id="F4">Distributions of phantom stock are made in shares of Merck Common Stock, with cash payable for partial shares, in accordance with a distribution schedule elected by the reporting person.  This distribution is subject to conditions and limitations of the Merck Deferral Program.</footnote>
        <footnote id="F5">Holdings include shares acquired in dividend reinvestment transactions.</footnote>
    </footnotes>

    <remarks></remarks>

    <ownerSignature>
        <signatureName>Debra A. Bollwage as Attorney-in-Fact for
Raymond V. Gilmartin</signatureName>
        <signatureDate>2005-01-07</signatureDate>
    </ownerSignature>
</ownershipDocument>

</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----